Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?

被引:39
|
作者
Holmer, Magnus [3 ]
Bendahl, Par-Ola [2 ]
Davidsson, Thomas [3 ]
Gudjonsson, Sigurdur [3 ]
Mansson, Wiking [3 ]
Liedberg, Fredrik [1 ]
机构
[1] Vaxjo Cty Hosp, Dept Urol, S-35185 Vaxjo, Sweden
[2] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[3] Univ Lund Hosp, Dept Urol, S-22185 Lund, Sweden
关键词
Bladder cancer; Cystectomy; Lymph node dissection; Time to recurrence; Disease-specific survival; RADICAL CYSTECTOMY; PELVIC LYMPHADENECTOMY; CANCER; IMPACT; PROGNOSIS; METASTASIS; SURVIVAL; SURGERY;
D O I
10.1007/s00345-008-0366-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We compared extended and limited lymph node dissections performed during radical cystectomy with regard to impact on survival and time to recurrence in bladder cancer patients. We analyzed 170 patients who underwent radical cystectomy for urothelial carcinoma between January 1997 and December 2005. From 1997 to 2000, 69 of the patients were subjected to limited lymph dissection that included perivesical nodes and nodes in the obturator fossa. In 2001-2005, the remaining 101 patients underwent extended lymph dissection that included perivesical nodes; nodes in the obturator fossa; the internal, external, and common iliac nodes; and the presacral nodes. Tumors penetrating the bladder wall (pT3 and pT4a) were more common in the extended than in the limited dissection group (48 and 33%, respectively). The median numbers of lymph nodes removed in the two groups were 37 and 8, respectively. Lymph node metastases were detected in 38% of the extended dissection patients but only in 17% of the limited dissection patients. There was no significant difference in survival or time to recurrence between the two groups. Subgroup analyses showed a significantly longer time to recurrence (HR 0.45, 95% CI 0.22-0.93; P = 0.032) in patients with non-organ-confined disease who underwent extended lymph node dissection. In a multivariate analysis adjusting for tumor stage, lymph node status, age, sex, and adjuvant chemotherapy, there was a significantly improved survival (HR 0.47, 95% CI 0.25-0.88; P = 0.018) and time to recurrence (HR 0.42, 95% CI 0.23-0.79; P = 0.007) in the patients with extended lymph node dissections. Extended lymph node dissection did not improve disease-specific survival, but was in multivariate analysis related to significantly improved disease-specific survival and prolonged time to recurrence in radical cystectomy patients. These results should be interpreted cautiously, since they might have been affected by stage migration and the shorter follow-up in the extended dissection group.
引用
收藏
页码:521 / 526
页数:6
相关论文
共 50 条
  • [1] Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?
    Magnus Holmer
    Pär-Ola Bendahl
    Thomas Davidsson
    Sigurdur Gudjonsson
    Wiking Månsson
    Fredrik Liedberg
    [J]. World Journal of Urology, 2009, 27 : 521 - 526
  • [2] EXTENDED LYMPH NODE DISSECTION IN PATIENTS WITH UROTHELIAL CELL CARCINOMA OF THE BLADDER: CAN IT MAKE A DIFFERENCE?
    Liedberg, F.
    Bendahl, P. O.
    Davidsson, T.
    Gudjonsson, S.
    Holmer, M.
    Mansson, W.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 256 - 256
  • [3] Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy
    Hwang, Eu Chang
    Sathianathen, Niranjan J.
    Imamura, Mari
    Kuntz, Gretchen M.
    Risk, Michael C.
    Dahm, Philipp
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (05):
  • [4] Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection
    Dhar, Nivedita Bhatta
    Campbell, Steven C.
    Zippe, Craig D.
    Derweesh, Ithaar H.
    Reuther, Alwyn M.
    Fergany, Amr
    Klein, Eric A.
    [J]. BJU INTERNATIONAL, 2006, 98 (06) : 1172 - 1175
  • [5] Re: Extended versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder in Patients Undergoing Radical Cystectomy
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (04): : 876 - 877
  • [6] FACTORS AFFECTING THE ADEQUACY OF LYMPH NODE YIELD IN EXTENDED PELVIC LYMPH NODE DISSECTION FOR UROTHELIAL BLADDER CANCER
    Freundlich, Robert
    Stamatakis, Lambros
    Sathyamoorthy, Kumaran
    Mital, Anuja
    Godoy, Guilherme
    Lerner, Seth
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E401 - E401
  • [7] CHANGE IN PATHOLOGICAL N-STAGE ASSOCIATED WITH EXTENDED LYMPH NODE DISSECTION AND RADICAL CYSTECTOMY IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER
    Godoy, Guilherme
    Stamatakis, Lambros
    Freundlich, Robert
    Chen, Guoqing
    Mital, Anuja
    Shoss, Jeffrey
    Madden-Fuentes, Ramiro
    Hong, Bumshik
    Lerner, Seth P.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E400 - E400
  • [8] Extended lymph node dissection: bladder, kidney
    Zehnder, Pascal
    Desai, Mihir
    [J]. CURRENT OPINION IN UROLOGY, 2011, 21 (02) : 110 - 114
  • [9] USE OF PERIOPERATIVE CHEMOTHERAPY IN PATIENTS TREATED WITH RADICAL CYSTECTOMY AND EXTENDED LYMPH NODE DISSECTION FOR UROTHELIAL CARCINOMA OF THE BLADDER AND THE EFFECT IN DOWNSTAGING AND SURVIVAL
    Starke, Nathan R.
    Godoy, Guilherme
    Amiel, Gilad E.
    Sonpavde, Guru
    Lerner, Seth P.
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E741 - E741
  • [10] IMPACT OF EXTENDED VERSUS STANDARD LYMPH NODE DISSECTION ON OVERALL SURVIVAL AMONG PATIENTS WITH UROTHELIAL CANCER OF BLADDER
    Abd El Latif, Ahmed
    Miocinovic, Ranko
    Stephenson, Andrew J.
    Campbell, Steven
    Fergany, Amr
    Gong, Michael C.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E707 - E707